Why did govt extend the interval between Covishield doses to 8 weeks?

The government has increased the time interval between the two doses of Covishield - the Oxford-AstraZeneca vaccine against Covid-19, from four-six weeks to four-eight weeks

Topics
Coronavirus Vaccine | Coronavirus | Coronavirus Tests

Sukanya Roy  |  New Delhi 

The government has increased the time interval between the two doses of Covishield — the Oxford-AstraZeneca vaccine against Covid-19, from four-six weeks to four-eight weeks.

Now, the question remains that why interval between the doses has been raised to 8 weeks? The ministry said in a statement that keeping the existing scientific evidence in mind, it appeared that protection from the vaccine was enhanced if the second dose of Covishield was administered between six and eight weeks but “not later than the stipulated period of eight weeks”.

Why did India increase the interval to eight weeks, and not longer? What do studies say about this vaccine's dosing interval? Who recommended to increased the time interval? What does this mean for India's ongoing vaccination campaign? Listen to the podcast to know


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Tue, March 23 2021. 15:06 IST
RECOMMENDED FOR YOU